CLINICAL_TRIALS
trial_result
· 2017-12-20
Clinical Trial Update: RDEA3170 and Allopurinol Combination Study in Gout Subjects [Phase 1]
Summary
Phase 1 trial update evaluating RDEA3170 in combination with allopurinol for gout; study completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ardea Biosciences, Inc. | Conditions: Gout | Phase 1 | Status: COMPLETED | Results posted: 2017-12-20